What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA on Tuesday approved bepirovirsen (Hibsago) as a potential functional cure for adults with chronic hepatitis B, but with no cirrhosis, who are taking antiviral therapy. Approval was based on findings from the B-Well 1...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.
Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.
A UTHealth Houston-led team has identified a promising new avenue to curb the growth and spread of tumors associated with hard-to-treat lung and other cancers.
The practice known as "free birth" — giving birth at home without a midwife — carries severe risks. But social media influencers are bringing attention and followers to the practice.
Newly developed palladium-coated membranes capture PFAS and use reactive hydrogen to break their carbon–fluorine bonds. During 58 days of continuous operation, the system achieved up to 96% removal…
